Homepage of SYNOPSIS

A platform for the Design of Synthetically Accessible Molecules with Desirable Properties in Medicine and Material Sciences


Synopsis is a de novo design platform that distinguishes itself from existing algorithms for molecular design in that it

  1. explicitly addresses the synthetic accessibility of the designed compounds
  2. can be used in combination with any other molecular modeling software

Synopsis is maintained and distributed by FD Computing, a privately owned company managed by Frits Daeyaert and located in Beerse, Belgium. It has been licenced to both industrial and academic users. Additionally, we offer to deploy Synopsis in combination with our own molecular design expertise and software tools as a service to users that have no in-house computational chemistry capacity.

For more information, please visit our synopsis and applications pages, or contact us.

last updated: March 2018